Advertising
Showing 1 to 15 of 19 entries
DON'T BUY
Wall Street has left certain "pandemic" stocks for dead. They offer a valuable product that will expand its reach. But more business deals will be done face to face after Covid. DOCU is trading at 56x PE even after falling from highs. DOCU flew too high during Covid.
Technology
DON'T BUY
Reported a miss He had puts at the 95 put strike. My gosh. When this stock is taken out, it's not at 5-10%, but a quarter of the value of the company. Not good.
Technology
DON'T BUY
Represents change from risk-on to risk-off in markets. Peaked at over $300, now below $100. No fundamental floor, so nothing to support it besides a concept, albeit a good one. Extremely expensive at 7x revenue, doesn't make any money. Don't be lured by stocks that fall precipitously, as there may be no end in sight.
Technology
DON'T BUY
Cathy Wood bought a ton of shares after share plunged DOCU has a bright future, but this in the penalty box for a few quarters. As for Wood, he respects her, but wishes she would be more selective in what she buys.
Technology
DON'T BUY
They reported a terrible quarter and sank 42%. A poorly executed quarter and a slowdown in business that the CEO didn't see. But investors hid behind this in the wake of Omicron and got hit badly today. DOCU dragged down other tech stocks, too. It was trading at 150x earnings which made investors consider the value of tech stocks in general.
Technology
DON'T BUY
A Covid play, trading at 150x earnings, which is too rich. Pass though he's a little on the fence about this because he's a huge believer in their product.
Technology
COMMENT
An exciting company offering a technology that will be widely adopted, but the valuation is trading at 26x revenue (not earnings). Too high. Too much future success is already priced in.
Technology
HOLD
He's tempted to say buy. DOCU will come out of this pandemic strong.
Technology
WATCH
They're about to report. Valuation is ridiculous around 100x 2021, but they have earnings growth (likely a secular trend that won't fade). He's fascinated to see how it'll react post earnings. Sure, it's worth a look.
Technology
HOLD

This and Zoom and considered lockdown stocks and are currently out of favour, but he think this is worth holding long-term. But you must hold this for a long while.

Technology

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Jan 07/21, Down 20.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with DOCU has triggered its stop at $190. To remain disciplined, we recommend covering the position. We will look for better opportunities.
Technology
BUY
It is oddly stalled, flat-lining. It seems the business of making documents happen remotely should continue to do well as we recover.
Technology
DON'T BUY
It's down a lot from its high, and is part of the stay-at-home trade, which is way out of fashion now. He needs to see a good quarter to prove DOC isn't just a stay at home.
Technology
BUY on WEAKNESS
It's done incredibly well during the pandemic as e-signatures blossomed. Growth will continue, but that rate may slow this year. Also, the valuation is too high now. It's a growth-momentum name.
Technology

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
TOP PICK
Stockchase Research Editor: Michael O'Reilly As the roll out of vaccines is falling behind projections in North America, the prospect of continued growth in electronic document signings could likely continue, contrary to several analyst opinions. Pipe Sandler has taken this view and has upgraded their outlook on the stock to $300. We would buy this with a stop-loss at $190, looking to achieve $285 -- about 20% upside. (Analysts’ price target is $275.39)
Technology
Showing 1 to 15 of 19 entries

Docusign(DOCU-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 6

Total Signals / Votes : 10

Stockchase rating for Docusign is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Docusign(DOCU-Q) Frequently Asked Questions

What is Docusign stock symbol?

Docusign is a American stock, trading under the symbol DOCU-Q on the NASDAQ (DOCU). It is usually referred to as NASDAQ:DOCU or DOCU-Q

Is Docusign a buy or a sell?

In the last year, 10 stock analysts published opinions about DOCU-Q. 2 analysts recommended to BUY the stock. 6 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Docusign.

Is Docusign a good investment or a top pick?

Docusign was recommended as a Top Pick by on . Read the latest stock experts ratings for Docusign.

Why is Docusign stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Docusign worth watching?

10 stock analysts on Stockchase covered Docusign In the last year. It is a trending stock that is worth watching.

What is Docusign stock price?

On 2022-05-23, Docusign (DOCU-Q) stock closed at a price of $78.27.